Other substances

Temozolomide

An alkylating agent.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
1
 AI-suggested references
0
 Clinical trials

General information

Temozolomide on PubChem

Marketed as

EMOZOLOMIDE ACCORD; TEMODAL; TEMODAR; TEMOMEDAC; TEMOZOLOMIDE

 

Structure image - Temozolomide

CN1C(=O)N2C=NC(=C2N=N1)C(=O)N

Supporting references

Link Tested on Impact factor Notes Publication date
Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2
Membrane protein Small molecule In silico 		in silico 3.00

Predicted to bind SARS-CoV-2 Membrane protein.

 Mar/05/2021

AI-suggested references

Link Publication date
Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients with primary brain tumors: a prospective cohort study
May/15/2020
Export (.csv)